|
⚲
|
| Keyboard |
| China Molybdenum Co Ltd
✚
|
|
|---|---|
| CIK # | 0001447960 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001447960] | |
| 4 | [0001447960] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| TCR2 Therapeutics Inc | |
| China Molybdenum Co Ltd | |
| China Molybdenum Hong Kong Co Ltd | |
| Upnorth Investment Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
TCR2 Therapeutics Inc TCRR
Common Stock
|
2019-02-19 | Conversion | 322,902 | ||
|
TCR2 Therapeutics Inc TCRR
Common Stock
|
2019-02-19 | Conversion | 1,614,517 | ||
|
TCR2 Therapeutics Inc TCRR
Common Stock
|
2019-02-19 | Buy | 200,000 | $15.00 | 3,000,000 |
|
TCR2 Therapeutics Inc TCRR
Series B Preferred Stock · derivative
|
2019-02-19 | Conversion | 10,000,000 | ||
|
TCR2 Therapeutics Inc TCRR
Series A Preferred Stock · derivative
|
2019-02-19 | Conversion | 2,000,000 |